1 – 12 of 12
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Addressing the origins and health effects of small lungs
(
- Contribution to journal › Letter
- 2022
-
Mark
Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data : an observational, multicohort, retrospective analysis
(
- Contribution to journal › Article
- 2020
-
Mark
Obstructive sleep apnoea in acute coronary syndrome
(
- Contribution to journal › Letter
- 2018
-
Mark
Co-opting of ClinicalTrials.gov by patient-funded studies
(
- Contribution to journal › Debate/Note/Editorial
- 2017
-
Mark
Respiratory diseases in the marginal labour sectors : A call to action
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Occupational lung diseases : From old and novel exposures to effective preventive strategies
(
- Contribution to journal › Scientific review
-
Mark
Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency : an open-label extension trial (RAPID-OLE)
(
- Contribution to journal › Article
-
Mark
Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015 : a systematic analysis for the Global Burden of Disease Study 2015
- Contribution to journal › Article
-
Mark
A novel endpoint for exacerbations in asthma to accelerate clinical development : A post-hoc analysis of randomised controlled trials
(
- Contribution to journal › Article
-
Mark
Effectiveness of seasonal influenza vaccination in community-dwelling elderly people : an individual participant data meta-analysis of test-negative design case-control studies
(
- Contribution to journal › Article
- 2014
-
Mark
The rise and fall of COPD mortality.
(
- Contribution to journal › Debate/Note/Editorial
- 2013
-
Mark
Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials.
(
- Contribution to journal › Article